aspirin has been researched along with incb-018424 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geyer, H; Hensley, B; Mesa, R | 1 |
| Miyamoto, T; Yoshimoto, G | 1 |
| Hoffman, R; Kremyanskaya, M; Mascarenhas, J | 1 |
| Aumiller, J | 1 |
| Connor, C; Harrison, CN; Keohane, C; McLornan, DP; Radia, D; Sanchez, K | 1 |
| Harrison, C; Reiter, A | 1 |
| Usui, N | 1 |
| Besses, C; Griesshammer, M; Kiladjian, JJ | 1 |
4 review(s) available for aspirin and incb-018424
| Article | Year |
|---|---|
Polycythemia vera: current pharmacotherapy and future directions.
Topics: Alkylating Agents; Aspirin; Hematocrit; Hematologic Agents; Hematopoiesis; Humans; Hydroxyurea; Interferon-alpha; Janus Kinase 2; Nitriles; Polycythemia Vera; Polyethylene Glycols; Predictive Value of Tests; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Recombinant Proteins; Risk Assessment; Risk Factors; Treatment Outcome | 2013 |
[Treatment strategy for myeloproliferative neoplasms].
Topics: Adrenal Cortex Hormones; Aspirin; Calreticulin; Carbamates; Clinical Trials as Topic; Drug Therapy, Combination; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Immunosuppressive Agents; Janus Kinase 2; Molecular Targeted Therapy; Mutation; Nitriles; Platelet Aggregation Inhibitors; Polycythemia Vera; Primary Myelofibrosis; Prognosis; Pyrazoles; Pyrimidines; Quinazolines; Receptors, Thrombopoietin; Thalidomide; Thrombocythemia, Essential | 2014 |
Anagrelide hydrochloride and ruxolitinib for treatment of polycythemia vera.
Topics: Aspirin; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Hydroxyurea; Interferon-alpha; Nitriles; Platelet Aggregation Inhibitors; Polycythemia Vera; Polyethylene Glycols; Pyrazoles; Pyrimidines; Quinazolines | 2015 |
How We Identify and Manage Patients with Inadequately Controlled Polycythemia Vera.
Topics: Antineoplastic Agents; Aspirin; Humans; Hydroxyurea; Interferon-alpha; Janus Kinase 2; Nitriles; Polycythemia Vera; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Survival Rate | 2016 |
2 trial(s) available for aspirin and incb-018424
| Article | Year |
|---|---|
The effects of JAK inhibitor therapy upon novel markers of thrombosis In myeloproliferative neoplasms.
Topics: Aspirin; Biomarkers; Female; Hematologic Neoplasms; Humans; Janus Kinase 2; Male; Middle Aged; Nitriles; Polycythemia Vera; Pyrazoles; Pyrimidines; Pyrrolidines; Sulfonamides; Thrombocythemia, Essential; Thrombosis; Warfarin | 2015 |
Thromboembolic events in polycythemia vera.
Topics: Age Factors; Anticoagulants; Aspirin; Humans; Hydroxyurea; Interferons; Nitriles; Phlebotomy; Polycythemia Vera; Pyrazoles; Pyrimidines; Risk Factors; Thromboembolism; Thrombosis | 2019 |
2 other study(ies) available for aspirin and incb-018424
| Article | Year |
|---|---|
[Polycythemia vera: the disadvantages of overproduction].
Topics: Aged; Aspirin; Bloodletting; Diagnosis, Differential; Female; Hematocrit; Humans; Hydroxyurea; Interferons; Male; Middle Aged; Nitriles; Polycythemia Vera; Pyrazoles; Pyrimidines; Thromboembolism | 2015 |
JSH guideline for tumors of hematopoietic and lymphoid tissues-lukemia: 4. Chronic myelogenous leukemia (CML)/myeloproliferative neoplasms (MPN).
Topics: Algorithms; Aniline Compounds; Antineoplastic Agents; Aspirin; Blood Transfusion; Dasatinib; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Imidazoles; Japan; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Myeloproliferative Disorders; Nitriles; Phlebotomy; Prognosis; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrazoles; Pyridazines; Pyrimidines; Quinazolines; Quinolines; Risk | 2017 |